144 related articles for article (PubMed ID: 22282986)
1. Separation of initiating and promoting effects of the skin carcinogen 7-bromomethylbenz(a)anthracene.
Scribner NK; Scribner JD
Carcinogenesis; 1980 Jan; 1(1):97-100. PubMed ID: 22282986
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
3. Tumor initiating activity of 9- and 10-fluoro-7,12-dimethylbenz[a]-anthracene (DMBA) and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on tumor initiation by monofluoro derivatives of DMBA in SENCAR mice.
DiGiovanni J; Decina PC; Diamond L
Carcinogenesis; 1983 Aug; 4(8):1045-9. PubMed ID: 6409443
[TBL] [Abstract][Full Text] [Related]
4. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
6. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin.
Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG
Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189
[TBL] [Abstract][Full Text] [Related]
7. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
8. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice.
DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ
Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143
[TBL] [Abstract][Full Text] [Related]
9. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons.
DiGiovanni J; Rymer J; Slaga TJ; Boutwell RK
Carcinogenesis; 1982; 3(4):371-5. PubMed ID: 6284398
[TBL] [Abstract][Full Text] [Related]
10. Further investigations into the effect of non-benzo ring bay-region methyl substituents on tumor-initiating activity of polycyclic hydrocarbons.
Sawyer TW; Chang K; Harvey RG; DiGiovanni J
Cancer Lett; 1987 Sep; 36(3):317-24. PubMed ID: 3115560
[TBL] [Abstract][Full Text] [Related]
11. Mouse skin tumor initiating activity of fluorinated derivatives of 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene.
Nair RV; Walker SE; Sharma PK; Witiak DT; DiGiovanni J
Chem Res Toxicol; 1992; 5(2):153-6. PubMed ID: 1643244
[No Abstract] [Full Text] [Related]
12. 7,12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo.
Frenkel K; Wei L; Wei H
Free Radic Biol Med; 1995 Sep; 19(3):373-80. PubMed ID: 7557552
[TBL] [Abstract][Full Text] [Related]
13. Analysis of highly polar DNA adducts formed in SENCAR mouse epidermis following topical application of dibenz[a,j]anthracene.
Vulimiri SV; Baer-Dubowska W; Harvey RG; Zhang JT; DiGiovanni J
Chem Res Toxicol; 1999 Jan; 12(1):60-7. PubMed ID: 9894019
[TBL] [Abstract][Full Text] [Related]
14. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.
Wislocki PG; Gadek KM; Chou MW; Yang SK; Lu AY
Cancer Res; 1980 Oct; 40(10):3661-4. PubMed ID: 6777036
[No Abstract] [Full Text] [Related]
16. Retinoic acid promotion of papilloma formation in mouse skin.
Hennings H; Wenk ML; Donahoe R
Cancer Lett; 1982; 16(1):1-5. PubMed ID: 6811129
[TBL] [Abstract][Full Text] [Related]
17. Dibenz[a,c]anthracene: a potent inhibitor of skin-tumor initiation by 7,12-dimethylbenz[a]anthracene.
Slaga TJ; Viaje A; Buty SG; Bracken WM
Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):477-83. PubMed ID: 418469
[TBL] [Abstract][Full Text] [Related]
18. Potent antitumor promoting activity of N-6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, in mouse skin tumor formation induced by 7,12-dimethylbenz[a]anthracene plus teleocidin.
Nishino H; Iwashima A; Nakadate T; Kato R; Fujiki H; Sugimura T
Carcinogenesis; 1984 Feb; 5(2):283-5. PubMed ID: 6421505
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by quercetin of the promoting effect of teleocidin on skin papilloma formation in mice initiated with 7,12-dimethylbenz[a]anthracene.
Nishino H; Iwashima A; Fujiki H; Sugimura T
Gan; 1984 Feb; 75(2):113-6. PubMed ID: 6428958
[TBL] [Abstract][Full Text] [Related]
20. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
